BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,027 | +18.4% | 6,519 | +27.2% | 0.00% | 0.0% |
| Q1 2023 | $207,829 | -37.6% | 5,124 | -21.6% | 0.00% | -40.0% |
| Q4 2022 | $333,089 | -9.5% | 6,535 | -4.4% | 0.01% | 0.0% |
| Q3 2022 | $368,000 | -18.0% | 6,835 | -2.3% | 0.01% | -16.7% |
| Q2 2022 | $449,000 | -12.0% | 6,994 | +6.8% | 0.01% | 0.0% |
| Q1 2022 | $510,000 | -12.5% | 6,549 | -3.2% | 0.01% | -14.3% |
| Q4 2021 | $583,000 | +8.4% | 6,764 | +1.4% | 0.01% | 0.0% |
| Q3 2021 | $538,000 | -3.1% | 6,671 | -2.9% | 0.01% | -12.5% |
| Q2 2021 | $555,000 | -3.5% | 6,868 | +1.1% | 0.01% | -11.1% |
| Q1 2021 | $575,000 | +1.4% | 6,794 | -3.6% | 0.01% | 0.0% |
| Q4 2020 | $567,000 | -0.2% | 7,050 | +0.2% | 0.01% | -18.2% |
| Q3 2020 | $568,000 | -11.5% | 7,036 | -5.3% | 0.01% | -15.4% |
| Q2 2020 | $642,000 | -44.0% | 7,433 | -47.2% | 0.01% | -48.0% |
| Q1 2020 | $1,146,000 | -3.1% | 14,074 | -0.3% | 0.02% | +13.6% |
| Q4 2019 | $1,183,000 | -2.4% | 14,111 | +2.1% | 0.02% | -8.3% |
| Q3 2019 | $1,212,000 | -5.3% | 13,824 | -11.6% | 0.02% | -7.7% |
| Q2 2019 | $1,280,000 | -3.7% | 15,633 | -4.4% | 0.03% | -7.1% |
| Q1 2019 | $1,329,000 | +102.6% | 16,355 | +63.9% | 0.03% | +75.0% |
| Q4 2018 | $656,000 | -64.6% | 9,978 | -58.4% | 0.02% | -61.0% |
| Q3 2018 | $1,851,000 | +34.8% | 24,014 | +29.1% | 0.04% | +20.6% |
| Q2 2018 | $1,373,000 | +48.3% | 18,601 | +30.6% | 0.03% | +41.7% |
| Q1 2018 | $926,000 | -1.1% | 14,242 | -1.7% | 0.02% | +4.3% |
| Q4 2017 | $936,000 | +0.2% | 14,495 | -2.6% | 0.02% | -8.0% |
| Q3 2017 | $934,000 | +8.4% | 14,887 | +4.5% | 0.02% | +4.2% |
| Q2 2017 | $862,000 | +3.0% | 14,248 | -11.7% | 0.02% | 0.0% |
| Q1 2017 | $837,000 | +9.6% | 16,142 | -6.3% | 0.02% | 0.0% |
| Q4 2016 | $764,000 | +3.2% | 17,234 | +10.8% | 0.02% | 0.0% |
| Q3 2016 | $740,000 | +8.5% | 15,556 | +3.0% | 0.02% | +9.1% |
| Q2 2016 | $682,000 | +48.6% | 15,103 | +34.9% | 0.02% | +37.5% |
| Q1 2016 | $459,000 | +6.2% | 11,195 | -1.2% | 0.02% | +6.7% |
| Q4 2015 | $432,000 | +13.7% | 11,330 | -2.3% | 0.02% | +7.1% |
| Q3 2015 | $380,000 | -54.4% | 11,595 | -2.7% | 0.01% | -50.0% |
| Q2 2015 | $833,000 | -16.9% | 11,921 | -18.6% | 0.03% | -17.6% |
| Q1 2015 | $1,003,000 | -8.7% | 14,652 | -2.3% | 0.03% | -5.6% |
| Q4 2014 | $1,099,000 | +17.9% | 15,002 | +15.5% | 0.04% | +16.1% |
| Q3 2014 | $932,000 | +9.1% | 12,993 | +5.8% | 0.03% | -3.1% |
| Q4 2013 | $854,000 | -4.9% | 12,280 | -10.2% | 0.03% | -11.1% |
| Q3 2013 | $898,000 | +15.6% | 13,672 | +21.9% | 0.04% | +12.5% |
| Q2 2013 | $777,000 | – | 11,218 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |